Inhibition of the Sterol Regulatory Element Binding Protein SREBF-1 Overcomes Docetaxel Resistance in Advanced Prostate CancerMaximilian Peter Brandt(Johannes Gutenberg University Mainz), Martin Puhr(Innsbruck Medical University)American Journal Of PathologyAugust 19, 202410.1016/j.ajpath.2024.07.019Cited by 3SaveCiteExport RISWatch citationsRelated PapersSOCS-3 antagonises the proliferative and migratory effects of fibroblast growth factor-2 in prostate cancer by inhibition of p44/p42 MAPK signalling|Endocrine Related Cancer|2010|41Glucocorticoid treatment influences prostate cancer cell growth and the tumor microenvironment via altered glucocorticoid receptor signaling in prostate fibroblasts|Oncogene|2023|19